Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 5, 2026
Back to directoryAI-enabled CCTA analysis platform for coronary plaque assessment and heart attack prevention workflows.
Cardiology and imaging teams using CCTA to quantify and track coronary plaque.
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Cleerly as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Confirm product-specific clearance, Rx-only status, trained-user requirements, indication, eligible CCTA acquisition protocol, and geography before using plaque analysis in a clinical pathway. |
|---|---|
| Privacy | Review coronary CTA upload, cloud processing, image retention, report distribution, authorized users, application access, and data-use terms for cardiology workflows. |
| Evidence | Evaluate evidence for the intended patient population, scanner protocols, plaque metrics, downstream testing, preventive treatment decisions, and follow-up outcomes. |
| Workflow | Best governed as cardiologist-reviewed CCTA analysis feeding structured prevention or treatment-planning workflows, not as autonomous cardiovascular diagnosis. |
Cleerly describes AI-enabled CCTA coronary plaque analysis for comprehensive and trackable insights; its indications page says Cleerly Labs is Rx-only software for trained medical professionals and should not replace qualified practitioner judgment.
Not for: General cardiovascular diagnosis without clinician interpretation and validated workflow.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.